Product Information
VALGANCICLOVIR HCL 50 MG/ML is a generic product labeled by Granules Pharmaceuticals Inc., priced at $1.0058 per ML under NDC 70010005140. Its NADAC has been published 181 times since Sep 21, 2022.
FDA first approved this application on Jan 31, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/mL
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010005140
Classification
Generic
Dosage Form
FOR SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VALGANCICLOVIRApproval Type
Generic (ANDA)
FDA Application
ANDA213306FDA Approved
1/31/2020
TE Code
AB
On Market Since
7/1/2021
Pharmacological Classes
Price Statistics
The NADAC for VALGANCICLOVIR HCL 50 MG/ML has been published 181 times since Sep 21, 2022, and over the history we have for it it has declined 79.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0058 per ML |
|---|---|
| All-time high | $4.9284 (Sep 13, 2023) |
| All-time low | $0.9898 (Aug 19, 2026) |
| 52-week high | $1.4406 |
| 52-week low | $0.9898 |
| Median price | $2.2436 |
| Average price | $2.7728 |
| Largest weekly change | -30.0% (Apr 17, 2024) |
| Weeks tracked | 181 |
| Tracking since | Sep 21, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Granules Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
VALGANCICLOVIR market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VALGANCICLOVIR HCL 50 MG/ML?
The current National Average Drug Acquisition Cost (NADAC) for VALGANCICLOVIR HCL 50 MG/ML, manufactured by Granules Pharmaceuticals Inc., is $1.0058 per ML (NDC 70010005140), effective Sep 30, 2026.
How has the price of VALGANCICLOVIR HCL 50 MG/ML changed over time?
Over the history we have for it, the NADAC for VALGANCICLOVIR HCL 50 MG/ML has declined 79.6%. It has been tracked across 181 weekly CMS publications since Sep 21, 2022.
What are the highest and lowest recorded NADAC prices for VALGANCICLOVIR HCL 50 MG/ML?
Since Sep 21, 2022, the NADAC for VALGANCICLOVIR HCL 50 MG/ML has ranged from a low of $0.9898 (Aug 19, 2026) to a high of $4.9284 (Sep 13, 2023), with a median of $2.2436 per ML.
Are there cheaper alternatives to VALGANCICLOVIR HCL 50 MG/ML?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VALGANCICLOVIR HCL 50 MG/ML in a comparable dosage form, but none are currently priced below it.
Who manufactures VALGANCICLOVIR HCL 50 MG/ML?
VALGANCICLOVIR HCL 50 MG/ML (NDC 70010005140) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.